Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
'March-in' drug pricing provisions advance in the US
While “march-in” rights have yet to materialize in the U.S., the controversial price-cutting measure seems to be gaining traction with the government.
Fraiser Kansteiner
Dec 7, 2023 11:58am
Lilly's Verzenio barely misses overall survival goal in 1L
Dec 6, 2023 10:00am
Novartis follows peers as it launches a corporate rebranding
Dec 5, 2023 4:22am
Pfizer is the target of another lawsuit from Texas AG Paxton
Dec 1, 2023 11:11am
GSK CEO still sees plenty of 'headroom for growth' for RSV shot
Nov 30, 2023 4:32pm
Pfizer's cost-cutting drive rolls on with CT layoffs expected
Nov 30, 2023 11:11am
